Literature DB >> 11731401

Risk of macular degeneration with statin use should be interpreted with caution.

R van Leeuwen, J R Vingerling, P T de Jong.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11731401      PMCID： PMC1121762     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Risk of macular degeneration in users of statins: cross sectional study.

Authors:  N F Hall; C R Gale; H Syddall; D I Phillips; C N Martyn
Journal:  BMJ       Date:  2001-08-18

Review 2.  An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

Authors:  A C Bird; N M Bressler; S B Bressler; I H Chisholm; G Coscas; M D Davis; P T de Jong; C C Klaver; B E Klein; R Klein
Journal:  Surv Ophthalmol       Date:  1995 Mar-Apr       Impact factor: 6.048

3.  The prevalence of age-related maculopathy in the Rotterdam Study.

Authors:  J R Vingerling; I Dielemans; A Hofman; D E Grobbee; M Hijmering; C F Kramer; P T de Jong
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079
  3 in total
  7 in total

1.  The association between statin use and age related maculopathy.

Authors:  G McGwin; C Owsley; C A Curcio; R J Crain
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration.

Authors:  J L Duncan
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 3.  Do statins have a role in the prevention of age-related macular degeneration?

Authors:  Sean W Tsao; Donald S Fong
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

4.  Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study.

Authors:  Ronald Klein; Yingzi Deng; Barbara E K Klein; Leslie Hyman; Johanna Seddon; Robert N Frank; Robert B Wallace; Susan L Hendrix; Baruch D Kuppermann; Robert D Langer; Lewis Kuller; Robert Brunner; Karen C Johnson; Asha M Thomas; Mary Haan
Journal:  Am J Ophthalmol       Date:  2007-01-10       Impact factor: 5.258

5.  A case control study of age related macular degeneration and use of statins.

Authors:  L Smeeth; C Cook; U Chakravarthy; R Hubbard; A E Fletcher
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

6.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

7.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.